Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$2.78 USD
-0.12 (-4.14%)
Updated May 15, 2024 04:00 PM ET
After-Market: $2.79 +0.01 (0.36%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AWH 2.78 -0.12(-4.14%)
Will AWH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AWH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AWH
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
AWH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
All You Need to Know About Aspira (AWH) Rating Upgrade to Buy
ReWalk Robotics (RWLK) Reports Q2 Loss, Tops Revenue Estimates
Other News for AWH
Aspira Womens Health Inc (AWH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
AWH Stock Earnings: Aspira Womens Health Misses EPS, Misses Revenue for Q1 2024
Aspira Women's Health Inc. (AWH) Q1 2024 Earnings Call Transcript
Aspira: Q1 Earnings Snapshot
Aspira Women’s Health Reports First Quarter 2024 Financial Results